Skip to main content
Publication date
2017 Nov 01
Authors
Esserman, LJ Yau, C Thompson, CK van't Veer, LJ Borowsky, AD Hoadley, KA Tobin, NP Nordenskjold, B Fornander, T Stal, O Benz, CC Lindstrom, LS
Author KI Usernames
Fornander, T|tomfor Lindstrom, LS|lilind Lindström, LS|lilind Tobin, NP|nictob
Pubmed ID
28662222
Journal
JAMA oncology
Doctype
Article
KI Connection
Hög
Mesh SV
Behandlingsresultat Bröstbevarande kirurgi Brösttumörer Cellgifter, hormonella DNA-mikromatrisanalys Genuttrycksmönster Immunhistokemi Kaplan-Meiers skattning Kvinnlig Läkemedelsterapi, understödjande Mastektomi Medelålders personer Multivariantanalys Människa Prediktivt värde av tester Proportional hazard-modeller Riskbedömning Riskfaktorer Sjukdomsfri överlevnad Sverige Tamoxifen Tidsfaktorer Transkripton Tumörbörda Tumörmarkörer Understödjande strålbehandling
Mesh EN
Antineoplastic Agents, Hormonal Biomarkers, Tumor Breast Neoplasms Chemotherapy, Adjuvant Disease-Free Survival Gene Expression Profiling Immunohistochemistry Kaplan-Meier Estimate Mastectomy Mastectomy, Segmental Multivariate Analysis Oligonucleotide Array Sequence Analysis Predictive Value of Tests Proportional Hazards Models Radiotherapy, Adjuvant Risk Assessment Risk Factors Sweden Tamoxifen Time Factors Transcriptome Treatment Outcome Tumor Burden
First date
2017-11-19T10:43:59.011Z